EN DE
Data-driven stock valuation

Concentra Group Holdings Parent, Inc. (CON) fair value: what the stock is really worth

We calculate from audited financials what Concentra Group Holdings Parent, Inc. is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily, free.

  1. Compare price with fair valuebelow fair value = cheap, above = expensive
  2. Check the quality50 and up solid, 75 and up strong
  3. Watch it or check another stockalert when fair value or trend changes

Healthcare · US · Market cap $4.4B · ISIN US20603L1026

At a glance

CG Concentra Group Holdings Parent, Inc. logo Concentra Group Holdings Parent, Inc. CON · US
Price$34.24
Fair Value$27.71
Upside−19.1%
Quality62/100

A solid business, but trading 24% above our fair value of $27.71.

As of Aug 19, 2026, the fair value of Concentra Group Holdings Parent, Inc. is $27.71 per share against a price of $34.24, so the fair value sits 19% below the price. A model estimate from reported figures, not an analyst target.

!Mixed Growth (revenue 3y +7.9 %/yr)
!Thin margins · 8.0% net margin
!High debt · generates free cash flow
·0.73% dividend yield
!Mixed vs. peers (6/14)
!Moderate moat 64/100
!The models disagree: range $10.63 to $50.13
!Weak on valuation: 8 out of 100
!Weak on dividend: 15 out of 100
Evidence: High Range $10.63 to $50.13

Fair value as of: Aug 19, 2026

From 26 valuation models · updated 22 days ago

Share price +3.7% over the past month.

Watch Concentra Group Holdings Parent, Inc. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

What matters now

  • The model range is unusually wide ($10.63 to $50.13). The outcome hinges heavily on assumptions, so read the point estimate with caution.
  • Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.

Price vs Fair Value (2 years)

$35.53 $18.56 Fair Value $27.71 Jul 2024 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 19, 2026.

How to read this chart

26‑month range $18.56 – $35.53 · fair‑value band $10.63 – $50.13 · the $34.24 price screens above the $27.71 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 19, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Concentra Group Holdings Parent, Inc. (CON) currently trades at $34.24, while our model-based Fair Value estimate is $27.71, implying the stock looks roughly 23.6% overvalued today. The Quality Score stands at 62/100 (solid quality), in the Healthcare sector. Bull case: the Growth Earnings group reads highest at a median of $26.86 per share, and 0 of the 26 models we run sit above the $34.24 price. Bear case: the Dividend Discount group reads lowest at $3.70, and 26 of the 26 models stay below the price. Evidence for this calculation is high.

Over the trailing twelve months, Concentra Group Holdings Parent, Inc. generated revenue of $2.2B at a net margin of 8.0%. Revenue grew 13.7% year over year. It earns a return on equity of 47.0%. Net debt stands at $2.0B. Fundamentals as of Aug 19, 2026

Scenario range: $10.63 (bear) to $50.13 (bull), the price of $34.24 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target. The share trades near its 52-week high and 86% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −19%, CON screens richer than that median.

Fair Value models

Based on fiscal year 2025 figures (about 8 months old). Earnings retained since then ($0.7933 per share) are deliberately not added.

Each model values the company its own way; the fair value above is the evidence-weighted blend. Evidence (0 to 100) shows how complete a model's inputs are. How we calculate →

Model Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
EPV best evidence $6.43 $9.28 $11.74 73
FCF DCF $5.34 $14.81 $28.95 71
Growth DCF $5.52 $13.73 $25.19 71
All 26 models by family
DCF Models
FCF DCF $5.34 $14.81 $28.95 71
Owner Earnings $2.70 $10.68 $22.62 66
5Y Revenue Exit $7.78 $20.54 $37.02 65
5Y EBITDA Exit $12.38 $29.26 $49.24 69
5Y P/E Exit $7.24 $19.51 $32.54 64
10Y Revenue Exit $6.06 $17.37 $32.97 59
10Y EBITDA Exit $9.58 $23.34 $42.21 62
10Y P/E Exit $6.36 $16.67 $29.57 58
Earnings-Based
Graham-Dodd $9.18 $30.71 $41.13 62
Lynch FV $6.98 $9.97 $12.96 58
PEG = 1.0 $6.98 $9.97 $12.96 55
EPV best evidence $6.43 $9.28 $11.74 73
Dividend Discount
Gordon GGM $2.20 $4.39 $6.64 64
DDM Multi-Stage $2.20 $3.70 $4.63 64
Multiples
P/E Multiple $22.28 $29.71 $37.14 63
P/S Multiple $17.22 $22.96 $28.70 58
P/B Multiple $10.37 $13.83 $17.29 55
EV/EBIT $18.77 $28.89 $39.02 65
EV/EBITDA $19.63 $30.04 $40.45 66
EV/Revenue $10.08 $19.37 $28.65 51
Asset-Based
NCAV (Graham) $1.54 $2.06 $3.07 54
Growth DCF
Growth DCF $5.52 $13.73 $25.19 71
Rev-Margin DCF $7.78 $20.42 $35.20 66
Economic Profit
Residual Income $10.88 $17.93 $294.14 61
ROIC Compounder $7.27 $12.27 $18.44 67
Growth Earnings
Growth-Adj P/E $18.80 $26.86 $34.91 65

Widest divergence: Growth Earnings ($26.86) versus Asset-Based ($2.06). Highest evidence: EPV (73).

Notify me when CON reaches fair value

Put CON on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 24.5
P/S ratio 1.95 P/E × margin
EPS (TTM) $1.40 price ÷ EPS = P/E 24.5
Dividend yield 0.7% payout 17.9%
Net margin 8.0% FY2025
Return on equity 47.0% TTM
More key figures
Profitability
Return on assets (EBIT) 25.9% avg 4y
Operating margin 17.0% TTM
Growth
Revenue (TTM) $2.2B TTM
Revenue growth (YoY) +13.7% 3y avg +7.9%
EPS growth (YoY) +29.4%
Balance sheet & cash flow
Free cash flow $197M FY2025
Net debt $2.0B FY2025 · ≈ 10.3 yrs of FCF

Figures from reported company fundamentals · as of Aug 19, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 62/100

Of which business quality 58 · Market factors (momentum, volatility) 88

Profitability 54
Margins and returns on capital today
Quality Growth 47
Are margins and returns improving?
Cashflow 58
Earnings quality: real cash, not paper profit
Fin. Strength 43
Balance sheet, leverage, solvency risk
Investment 80
Disciplined investing over empire-building
Low Volatility 72
Calm price path (market factor)
Momentum 92
Price trend over the last 3–12 months (market factor)
52W Momentum 98
Distance to the 52-week high (market factor)
Net Issuance 79
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business.

Full company description

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Concentra Group Holdings Parent, Inc. reported revenue of $2.2B in FY2025 versus $1.7B in FY2021, a compound +5.7%/yr. Reported net income was $173M in FY2025, compounding −4.6%/yr from FY2021.

Growth Quality 81/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$2.2B
Latest YoY
+13.9%
Avg. revenue growth/yr (3Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+7.9%
Value creation/yr (5Y) ⓘEarnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year.
−3.3%
Earnings growth per share plus dividend yield: the value created per share and year.
Earnings growth per share−4.0%
Dividend yield0.7%
Operating margin (EBIT) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15.6% (2021) → 16.0% (2024) · steady
Revenue +5.7%/yr
FY21 $1.7B
FY22 $1.7B
FY23 $1.8B
FY24 $1.9B
FY25 $2.2B
Net income −4.6%/yr
FY21 $209M
FY22 $167M
FY23 $180M
FY24 $167M
FY25 $173M

CON screens 24% overvalued. Compare with HCA Healthcare, Inc →

Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Concentra Group Holdings Parent, Inc. · Fair Value
$27.71 −24%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Concentra Group Holdings Parent, Inc. Fair Value". https://www.fairvalue-calculator.com/stock/CON

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Medical Care Facilities · 257 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation
Quality Score 62 · Above median
Fair Value upside −20% · Below median
Profitability
Return on equity (TTM) 47% · Top 25%
Return on assets 8% · Top 25%
Net margin (TTM) 8% · Above median
Operating margin (TTM) 17% · Top 25%
Growth and dividend
Revenue growth 14% · Above median
Dividend yield (TTM) 0.7% · Below median
Balance sheet
Debt / equity 3.98× · Highest 25%

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/E (TTM) 24.5× · Pricier than median
P/B 10.27× · Priciest 25%
P/S (TTM) 1.81× · Pricier than median
P/FCF 20.5× · Priciest 25%
EV/EBITDA 12.6× · Pricier than median

What the price implies (reverse DCF)

The inverse question: what free-cash-flow growth must Concentra Group Holdings Parent, Inc. deliver for ten years so that today's price is fair in our DCF model? Same formula, same discount rate as the fair value.

Implied FCF growth, 10 years+13.2 % per year
Achieved revenue growth, 4 years+5.7 % p.a.
Sector median revenue growth+4.4 %
FCF yield on price4.49 %
Discount rate (WACC) in the models9.7 %

The price demands an acceleration versus past growth: a high bar the company still has to clear. Ranking of the largest stocks →

Context: sector, industry, market

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE8 · sector 24
FUTURE69 · sector 26
PAST100 · sector 30
HEALTH0 · sector 90
DIVIDEND15 · sector 43

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 19, 2026).

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $405.00 $547.67 +35%
Fresenius SE FRE €44.69 €32.15 −28%
Dr. Sulaiman Al Habib Medical Services Group 4013 241.00 SAR 112.37 SAR −53%
IHH Healthcare Berhad, an investment holding company, Q0F 2.67 SGD 1.44 SGD −46%
Tenet Healthcare Corporation THC $265.05 $330.25 +25%
DaVita Inc DVA $183.99 $186.49 +1%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,818 ₹2,955 −66%
Fresenius Medical Care AG FMS $23.50 $46.42 +98%
Aier Eye Hospital Group 300015 ¥8.25 ¥7.67 −7%
Max Healthcare Institute Limited MAXHEALTH ₹1,005 ₹284.87 −72%

Compare Concentra Group Holdings Parent, Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Frequently asked questions

Is Concentra Group Holdings Parent, Inc. (CON) overvalued or undervalued?
As of Aug 19, 2026, our model estimates a fair value of $27.71 versus a price of $34.24, about −19% upside (overvalued).
What is the fair value of CON?
Our model-based fair value for Concentra Group Holdings Parent, Inc. is $27.71 (as of Aug 19, 2026), built from audited fundamentals. The current price: $34.24.
What is the quality score of CON?
Concentra Group Holdings Parent, Inc. has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Concentra Group Holdings Parent, Inc. (CON)?
Our model-based price target is the fair value of $27.71 (as of Aug 19, 2026) from 26 valuation models. Cautious scenario $10.63, optimistic scenario $50.13. It is a calculation from audited fundamentals, not an analyst target.
What is the Concentra Group Holdings Parent, Inc. stock forecast for 2026?
Our models put fair value at $27.71, about −19% upside versus a price of $34.24 (overvalued). Cautious scenario $10.63, optimistic scenario $50.13. The calculation is refreshed regularly with new filings.
What is the revenue of Concentra Group Holdings Parent, Inc. (CON)?
Concentra Group Holdings Parent, Inc. reported trailing-twelve-month revenue of about $2.2B (latest available figure, as of Aug 19, 2026).
What is the net profit margin of CON?
The net profit margin of Concentra Group Holdings Parent, Inc. is about 8.0%, meaning it keeps roughly 8.0% of revenue as net income. Based on the latest reported figures.
Does Concentra Group Holdings Parent, Inc. pay a dividend?
Concentra Group Holdings Parent, Inc. currently shows a dividend yield of about 0.73% relative to its recent price (as of Aug 19, 2026).
What growth is priced into Concentra Group Holdings Parent, Inc. (CON)?
For today's price to be fair in a discounted-cash-flow model, Concentra Group Holdings Parent, Inc. would have to grow free cash flow by +13.2 % per year for ten years (discount rate 9.7 %, then 2 % perpetual growth). Over the last 4 years revenue grew +5.7 % per year. As of Aug 19, 2026.
What discount rate (WACC) does the fair value of CON use?
Our models discount Concentra Group Holdings Parent, Inc. at 9.7 %: a base by market capitalisation (mid), country premium for USA. The same rate applies in all 26 models.
What is the intrinsic value of Concentra Group Holdings Parent, Inc. (CON)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Concentra Group Holdings Parent, Inc. it is $27.71 per share (as of Aug 19, 2026), against a price of $34.24. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Concentra Group Holdings Parent, Inc. stock overvalued or undervalued in 2026?
As of Aug 19, 2026, CON trades above its calculated fair value: price $34.24, fair value $27.71, a gap of about −19% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CON?
No. The price is what the market pays today ($34.24); the fair value is what the company's own numbers justify ($27.71). For Concentra Group Holdings Parent, Inc. the two are $6.53 per share apart. That gap is exactly why we show both numbers side by side.
How much is Concentra Group Holdings Parent, Inc. worth?
The market values Concentra Group Holdings Parent, Inc. at about $4.4B (market capitalisation, as of Aug 19, 2026). Per share that is $34.24; our models calculate a fair value of $27.71 per share.
What do the bullish and bearish scenarios say about CON?
Our models span a range for Concentra Group Holdings Parent, Inc.: cautious scenario $10.63, base $27.71, optimistic $50.13 per share (as of Aug 19, 2026, price $34.24). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CON?
Concentra Group Holdings Parent, Inc. trades at a price-to-earnings ratio of 24.5 (as of Aug 19, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $27.71 is built from several models across several years. Other multiples: P/B 10.3, P/S 1.8, EV/EBITDA 12.6.
How solid is the balance sheet of Concentra Group Holdings Parent, Inc. (CON)?
Balance-sheet figures for Concentra Group Holdings Parent, Inc. (as of Aug 19, 2026): return on equity 47.0%, debt of 3.98 per unit of equity. They feed the Quality Score of 62/100, which measures business quality independently of the share price.
How far is CON from its 52-week high?
Concentra Group Holdings Parent, Inc. trades at $34.24, about 29% below its 52-week high of $26.59 and 86% above the low of $18.39 (as of Aug 19, 2026). Distance from the high says nothing about value: that is what the fair value of $27.71 is for.
Which stocks are comparable to Concentra Group Holdings Parent, Inc.?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Concentra Group Holdings Parent, Inc. stock attractive at the current price?
The data as of Aug 19, 2026: price $34.24, calculated fair value $27.71 (−19%), Quality Score 62/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CON calculated?
We run Concentra Group Holdings Parent, Inc. through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $27.71, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 32.6 % above its aggregate fair value. Concentra Group Holdings Parent, Inc. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on <a href="/is-it-worth-investing-now/">is it worth investing now</a>.
Free · no account needed

Watch Concentra Group Holdings Parent, Inc. in the live analysis

One click puts Concentra Group Holdings Parent, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.